MENU
+Compare
EAPIF
Stock ticker: OTC
AS OF
Dec 19 closing price
Price
$2.63
Change
-$0.83 (-23.99%)
Capitalization
246.97M

EAPIF EUROAPI SA Forecast, Technical & Fundamental Analysis

Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics... Show more

EAPIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EAPIF with price predictions
Jan 14, 2026

EAPIF in upward trend: price expected to rise as it breaks its lower Bollinger Band on December 19, 2025

EAPIF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 7 cases where EAPIF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on EAPIF as a result. In of 22 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EAPIF just turned positive on January 12, 2026. Looking at past instances where EAPIF's MACD turned positive, the stock continued to rise in of 17 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

EAPIF moved below its 50-day moving average on December 16, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EAPIF crossed bearishly below the 50-day moving average on December 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for EAPIF entered a downward trend on January 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.226) is normal, around the industry mean (29.698). P/E Ratio (7.918) is within average values for comparable stocks, (76.061). EAPIF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.042). EAPIF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.242) is also within normal values, averaging (72.584).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EAPIF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EAPIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
EAPIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
15 rue Traversiere
Phone
N/A
Employees
N/A
Web
https://www.euroapi.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYEUX127.760.60
+0.47%
Rydex Europe 1.25x Strategy H
GIDHX8.730.04
+0.46%
Goldman Sachs Intl Eq Div & Prem Instl
JSJFX16.470.03
+0.18%
JHancock Small Cap Dynamic Growth R6
ASYLX14.52-0.03
-0.21%
AB Select US Long/Short Advisor
VRTTX591.12-2.60
-0.44%
Vanguard Russell 3000 Index I

EAPIF and Stocks

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
+1.32%
HLNCF - EAPIF
11%
Poorly correlated
+0.10%
IXHL - EAPIF
7%
Poorly correlated
+2.07%
AKAN - EAPIF
2%
Poorly correlated
-17.77%
ALVO - EAPIF
2%
Poorly correlated
+3.52%
More

Groups containing EAPIF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
Pharmaceuticals: Generic
industry (218 stocks)
4%
Poorly correlated
+0.49%